Healthcare Innovation and Patent Law’s ‘Pharmaceutical Privilege’: Is there a pharmaceutical privilege? And if so, should we remove it?

Dutfield, GM (2017) Healthcare Innovation and Patent Law’s ‘Pharmaceutical Privilege’: Is there a pharmaceutical privilege? And if so, should we remove it? Health Economics, Policy and Law, 12 (4). pp. 453-470. ISSN 1744-1331

Abstract

Metadata

Authors/Creators:
  • Dutfield, GM
Copyright, Publisher and Additional Information: (c) 2017, Cambridge University Press. This is an author produced version of a paper which has been published in Health Economics, Policy and Law, https://doi.org/10.1017/S1744133117000111 . This version is free to view and download for private research and study only. Not for re-distribution, re-sale or use in derivative works. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Patents; pharmaceuticals
Dates:
  • Published: October 2017
  • Accepted: 4 April 2017
  • Published (online): 18 April 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 12 Apr 2017 09:58
Last Modified: 13 Oct 2017 03:21
Status: Published
Publisher: Cambridge University Press (CUP)
Identification Number: https://doi.org/10.1017/S1744133117000111

Share / Export

Statistics